ANVSVSSLS• 7 Days (Normalized)
ANVS vs SLS (Annovis Bio Inc. vs SELLAS Life Sciences Group Inc.)
Showing Closing Date Range from Sep, 07 to Sep, 14, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ANVS Performance $1.14
-12.31%
Annovis Bio Inc.
Normalized Baseline0.00%
SLS Performance $11.73
-16.01%
SELLAS Life Sciences Group Inc.
Normalized Baseline0.00%
Alpha Spread Margin ANVS LEADS
+3.7%
ANVS outperforming by 3.70%
ANVSSLS
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ANVS SLS
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(5 dates)
| Date | ANVS Price | ANVS Gain (%) | SLS Price | SLS Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 14, 2026 | $1.14 | -12.31% | $11.73 | -16.01% | +3.70% |
| Sep 11, 2026 | $1.12 | -13.85% | $11.55 | -17.26% | +3.41% |
| Sep 10, 2026 | $1.19 | -8.46% | $13.49 | -3.37% | -5.09% |
| Sep 09, 2026 | $1.22 | -6.15% | $13.95 | -0.07% | -6.08% |
| Sep 08, 2026 | $1.30 | +0.00% | $13.96 | +0.00% | +0.00% |